COMMUNITY

ÃÖ°íÀÇ ±â¼ú·Â°ú ÃÖ»óÀÇ Ç°Áú,
ÂøÇÑ °¡°ÝÀ¸·Î º¸´äÇÏ¿© µå¸®°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ
Community

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÇÁ·Î¸ð¼Ç

ÇÁ·Î¸ð¼Ç

ÇÑÁ¤±â°£ ¾Æ¹Ù¹ÙÀÌ¿À Á¦°øÇϴ Ưº°ÇÑ °¡°Ý
Á¦¸ñ [BACHEM] Peptide Trends May 2019 – Cyclic Peptides
ÀÛ¼ºÀÚ abbabio
ÀÛ¼ºÀÏÀÚ 2019-05-17
Á¶È¸¼ö 286
MANAGE YOUR SUBSCRIPTION
BACHEM  PIONEERING  PARTNER  FOR PEPTIDES
PEPTIDE TRENDS
May 2019 EDITION
MEET US AT CEDARLANE EXPO
CedarLane Expo is Toronto¡¯s premier life science industry show. This year¡¯s event will be held on May 23, at the MaRS Centre, South Tower Auditorium, 101 College Street, Toronto.
Come to this free event to see what¡¯s new in the fields of stem cells, immunology, molecular biology, virology, diabetes, obesity, cancer research, and more! Talk directly with suppliers and discuss your projects with the product experts of Bachem!
We invite you to visit us at our Booth: we are excited to meet with you and learn your needs for peptides. Let us discuss how Bachem can assist to advance your research!
We look forward to meeting you at CedarLane Expo 2019!
Read More



CYCLIC PEPTIDES
Cyclic peptides play key roles in various processes and have excellent potential as therapeutics. Examples of cyclic peptide drugs are the hormone oxytocin and the immunosuppressant cyclosporine A.
Cyclic peptides possess several favorable properties as therapeutics. They display a large surface area, which leads to high affinity and selectivity for protein targets and their limited conformational flexibility reduces the entropic penalty upon binding, which in turn improves their binding properties.
Read More

CYCLIC PEPTIDES IN CLINICAL DEVELOPMENT
Naturally occurring cyclic peptides continue to be an inspiration for peptide drug design due to their resistance to enzyme degradation and enhanced protein binding affinity. Cyclic peptides often have better biological activity compared to linear peptides due to conformational rigidity. In recent years, this class of molecules has been propelled forward by the development of new methods to improve the drug-like properties of peptides by constraining their structure and the creation of new platforms to screen large libraries of cyclic molecules.
Read More

MEET BACHEM: MARIA RODRIGUEZ-WELSH, ASSISTANT PROJECT MANAGEMENT
This month the spotlight is on Maria Rodriguez-Welsh, Assistant Project Management at Bachem AG.
Learn about Maria¡¯s role at Bachem and what she likes to do in her free time.
Read More



PEPTIDE HIGHLIGHTS
This month's highlights include news about brominated tryptophan-containing peptides from marine animals, a peptide that shows promise for protecting kidneys from nephritis, a new approach to treat eye cancer, and a collagen IV-derived peptide that provides a new therapeutic approach for retina diseases.
Read More



LITERATURE CITATIONS
Bachem peptides and biochemicals are frequently cited in research publications. View a selection of recent articles that cite Bachem`s peptides.
Read More



Marketing
Dr. Martina Diekmann
Vice President Global Marketing

martina.diekmann@bachem.com
cell +41 79 945 9107
Marketing
Stefan Andlauer, EMBA
Director Science & Relationship Marketing
stefan.andlauer@bachem.com
phone +41 58 595 2107
CHAT WITH US!


MEET BACHEM AT UPCOMING EXHIBITS AND EVENTS
 
CedarLane Expo
Toronto, Canada
May 23, 2019

Bio International Convention
Philadelphia, PA, USA
June 3-6, 2019

CPhI China 2019
Shanghai, China
June 18-20, 2019

ISPE Biopharmaceutical Manufacturing Conference
Boston, MA, USA
June 18-20, 2019

American Peptide Symposium
Monterey, CA, USA
June 22-27, 2019

Make an appointment and meet us in person. Contact
|sasas

Bachem logo

           
Contact Us
÷ºÎÆÄÀÏ